Ron Creeley, vice president of marketing and sales for Simulations Plus, said: “We’re very pleased that the FDA’s cardiovascular and renal products division has licensed our ADMET Predictor software with all four of its modules.
“ADMET Predictor predicts almost 80 properties of molecules with only their molecular structure as input, including physicochemical, biopharmaceutical, metabolism, toxicity and some activity properties. The program has been consistently ranked first in accuracy in published comparison studies with competitive programs.”